Regarding amendments to the instructions for medical use of medicinal products containing ondansetron (ondansetron)
10.01.2022
1786
The Pharmacovigilance Risk Assessment Committee (PRAC), based on the assessment of the analysis of Periodic Safety Update Reports (PSURs) for medicinal products,…
Read more